← All diseases
Liver, kidneys and digestion
Liver cirrhosis
Would you like to receive a message when there is new research about Liver cirrhosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cirrhosis is available. View what Premium costs.
Publications and studies (3112)
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Comparison of underdilated versus standard transjugular intrahepatic portosystemic shunt in preventing rebleeding from oesophagogastric varices in patients with cirrhosis in Chinese tertiary hospitals: protocol for a multicentre randomised controlled trial (UVR-TIPS trial). (2026/08/05) ♡
- Patient awareness of viral hepatitis infection in Al-Madinah, Saudi Arabia: a cross-sectional study. (2026/08/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Modulation for Liver Regeneration in Hepatocellular Carcinoma: From Biological Mechanisms to Precision Regenerative Medicine. (2026/08/05) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Voluntary wheel running modulates murine gut microbiome during hyperammonemic stress. (2026/08/04) ♡
- Risk of HCC in Elderly Patients With MASLD: Proposal of an Effective Surveillance Strategy. (2026/08/04) ♡
- Validation of Liver Cirrhosis Network Criteria for Compensated Cirrhosis Through Natural Language Processing for Predicting Liver-Related Events. (2026/08/04) ♡
- Hepatic sarcoidosis presenting with portal hypertension without histologically established cirrhosis and reticular hepatic imaging features. (2026/08/04) ♡
- Liver transplant candidates with high frequency deceased donor offers. (2026/08/04) ♡
- Detailed racial/ethnic disparities in hepatocellular carcinoma risk with an electronic health record-based cohort. (2026/08/04) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis - To Suppress or Not to Suppress? (2026/08/03) ♡
- Absence of a Weekend Effect on In-Hospital Mortality in Upper Gastrointestinal Bleeding: A Multisite Study from an Integrated Health System. (2026/08/03) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. National guideline for hepatitis B elimination in Thailand: a decentralized health system model for expanding diagnosis and treatment. (2026/08/03) ♡
- Role of Renal Biomarkers in Sarcopenia or Frailty in Patients With Liver Cirrhosis. (2026/08/03) ♡
- A machine learning-derived aging-related gene signature for diagnosing HCV cirrhosis: Insights into immune microenvironment and therapeutic targets. (2026/08/03) ♡
- Computational screening of natural compounds reveals glycyrrhisoflavone as a potential Hepatitis B X-interacting protein inhibitor. (2026/08/03) ♡
- Clinical Outcome and Safety of Procedural Sedation and Analgesia Performed by Interventional Radiologists in Patients Undergoing Local Tumor Ablation of the Liver. (2026/08/02) ♡
- Passenger Lymphocyte Syndrome Triggered Hemolytic Anemia Following Orthotopic Liver Transplantation: A Case Report. (2026/08/02) ♡
- Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Emerging Trends and Research Hotspots in Gut Microbiota-Liver Fibrosis Research (2008-2025): A Bibliometric Analysis. (2026/08/01) ♡
- CD11c(+) T-Bet(+) B Cell Expansion Reveals a Distinct Pathogenic Signature in Autoimmune Liver Diseases. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Gut Microbiota, Immunity, and Metabolism in the Progression From Chronic Liver Disease to Hepatocellular Carcinoma. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future. (2026/08/01) ♡
- High-oxygen gas-permeable culture improves viability and supports quantitative antifibrotic pharmacology in precision-cut liver slices. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. General Hepatology Concerns for the Patient with Cholestatic Liver Disease. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. MASLD and Cardiovascular Risk: Mechanisms and Implications for Clinical Practice. (2026/08/01) ♡
- Photon-counting CT Extracellular Volume Fraction for Liver Fibrosis Assessment: Validation against MR Elastography and Histopathology. (2026/08/01) ♡
- Effects of Different Living Environments on Intestinal Flora in Patients With Schistosoma Japonicum-Induced Liver Fibrosis. (2026/08/01) ♡
- Artificial Intelligence/Machine Learning-Driven cfDNA Methylation Blood Test for Early Cancer Detection in Military Personnel With Environmental Toxin Exposure. (2026/08/01) ♡
- Unveiling Ferroptosis-Driven Mechanisms in Liver Fibrosis: A Bioinformatics Approach to Identify Novel Therapeutic Targets. (2026/08/01) ♡
- Rougan Granules ameliorates liver fibrosis through autophagy regulation: Insights from HPLC-Q-TOF-MS/MS, network pharmacology, and experimental validation. (2026/08/01) ♡
- Integrating network pharmacology and experimental validation to uncover the therapeutic mechanisms of Chaigui decoction in Schistosoma japonicum-induced liver fibrosis. (2026/08/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Is MASLD an independent risk factor for micro- and macrovascular complications of diabetes? A critical reappraisal and future directions. (2026/08/01) ♡
- Screening for Advanced Liver Fibrosis: Comparing Serum Indices With Elastography in a Nationally Representative U.S. Cohort. (2026/08/01) ♡
- Interpretation of China's Action Plan for Viral Hepatitis Prevention and Care (2025-2030). (2026/07/31) ♡
- Evaluation and management of heart failure patients with liver disease: European Journal of Heart Failure International Expert Position Paper. (2026/07/31) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Alcoholic cirrhosis with Wernicke encephalopathy: Clinical case report. (2026/07/31) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Morroniside ameliorates hepatic fibrosis in mice by targeting ACYP1 to promote NCOA4-mediated ferritinophagy and ferroptosis. (2026/07/31) ♡
- Rate and clinical predictors of skeletal muscle loss in patients with cirrhosis. (2026/07/30) ♡
- The impact of supervised aerobic and resistance exercise prehabilitation on frailty and recovery after living donor liver transplantation: Open-label randomized trial. (2026/07/30) ♡
- Jiawei Taohe Chengqi decoction alleviates angiogenesis associated with LECT2/CD209-mediated macrophage reprogramming in hepatic fibrosis. (2026/07/29) ♡
- Development of a liver cirrhosis-specific nutrition-focused physical examination tool: A modified Delphi study. (2026/07/29) ♡
- Handgrip strength and diameter-product-derived psoas area estimate in end-stage liver cirrhosis: an exploratory single-center analysis. (2026/07/29) ♡
- Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction-associated steatotic liver disease: A large multi-center cohort study. (2026/07/29) ♡
- High incidence of advanced liver disease and mortality in patients presenting with alcohol use disorder. (2026/07/29) ♡
- The Association of Dietary Macronutrient Quality and Mortality Among Patients With Liver Cirrhosis: A Prospective Cohort Study. (2026/07/29) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Advances in Precise Assessment of Portal Pressure in Porto-sinusoidal Vascular Disease. (2026/07/28) ♡
- Evaluation of the Safety and Efficacy of SOF/VEL Treatment and Pre-treatment of TAF in Patients with Chronic Hepatitis B Virus/Hepatitis C Virus Coinfection: A Multicenter Study. (2026/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Role of Nitric Oxide in Chronic Liver Disease: A Review. (2026/07/28) ♡
- Baseline Liver Fibrosis Severity Predicts Superior HBeAg Clearance and Fibrosis Reversal following Peg-IFNα plus Nucleos(t)ide Analog Therapy in HBeAg-positive Chronic Hepatitis B Patients. (2026/07/28) ♡
- Disentangling the hepatic risks of familial Mediterranean Fever and colchicine: A propensity score-matched analysis of 19,231 patients. (2026/07/28) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.